Edrophonium is a rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles. References: Yuan J, Zhang J, Zhang B, Hu W. The clinical features of patients concurrent with Guillain-Barre syndrome and myasthenia gravis. Neurosciences (Riyadh). 2018 Jan;23(1):66-70. doi: 10.17712/nsj.2018.1.20170209. PubMed PMID: 29455227.

纯度：≥98%

CAS：312-48-1